ENHABIT INC. DL -01
Enhabit, Inc. provides home health and hospice services in the United States. The company's home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, a… Read more
ENHABIT INC. DL -01 (X34) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, ENHABIT INC. DL -01 (X34) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ENHABIT INC. DL -01 - Net Assets Trend (None–None)
This chart illustrates how ENHABIT INC. DL -01's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ENHABIT INC. DL -01 (None–None)
The table below shows the annual net assets of ENHABIT INC. DL -01 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to ENHABIT INC. DL -01's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
ENHABIT INC. DL -01 Competitors by Market Cap
The table below lists competitors of ENHABIT INC. DL -01 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Anhui Liuguo Chemical Co Ltd
SHG:600470
|
$415.60 Million |
|
BAR HARBOR BANKSHS DL 2
F:42K
|
$415.71 Million |
|
YIDU TECH INC. DL -00002
F:0EL
|
$415.87 Million |
|
Shaanxi Zhongtian Rocket Technology
SHE:003009
|
$416.06 Million |
|
Opera Ltd
NASDAQ:OPRA
|
$415.59 Million |
|
Cuscal Limited
F:Y49
|
$415.52 Million |
|
Shanghai Canature Environmental
SHE:300272
|
$415.36 Million |
|
Episil Holding
TWO:3707
|
$415.29 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ENHABIT INC. DL -01's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares ENHABIT INC. DL -01's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently ENHABIT INC. DL -01 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares ENHABIT INC. DL -01's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,542,527,848
- Average return on equity (ROE) among peers: 7.82%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ENHABIT INC. DL -01 (X34) | €- | N/A | N/A | $415.59 Million |
| Raffles Medical Group Ltd (02M1) | $1.04 Billion | 8.64% | 0.46x | $548.22 Million |
| China Resources Medical Holdings Company Limited (1PH) | $6.14 Billion | 6.37% | 0.28x | $264.86 Million |
| Apollo Medical Holdings Inc (3AM) | $510.64 Million | 13.50% | 0.70x | $820.67 Million |
| NUVERRA ENVIR SOL (3H5) | $548.43 Million | -8.67% | 2.25x | $95.85 Million |
| Wenzhou Kangning Hospital Co. Ltd (4WK) | $1.04 Billion | 6.61% | 0.54x | $9.60 Million |
| Medicover AB (5M0B) | $562.10 Million | 18.11% | 2.00x | $967.15 Million |
| Ambea AB (publ) (6MA) | $4.68 Billion | 7.82% | 2.82x | $937.47 Million |
| Eifelhöhen-Klinik AG (EIF) | $18.66 Million | 24.17% | 2.10x | $4.38 Million |
| Garofalo Health Care S.p.A (GHC) | $333.14 Million | 6.51% | 1.55x | $126.70 Million |
| GZ4 (GZ4) | $545.91 Million | -4.85% | 4.17x | $116.32 Million |